Abstract
Fatigue is one of the most frequent complaints among breast cancer survivors. However, mechanisms underlying persisting fatigue after end of treatment are poorly understood. To explore whether biological processes underlying persistent fatigue can affect gene expression of blood cells, genome-wide expression analyses were performed on whole blood samples from breast cancer survivors classified as chronic fatigued 2–6 years after diagnosis. Non-fatigued survivors served as controls. Several gene sets involved in plasma- and B-cell pathways differed between the chronic fatigued and the non-fatigued, suggesting that a dysregulation in these pathways is associated with chronic fatigue and that a B-cell-mediated inflammatory process might underlie fatigue. The chronic fatigued also had a higher level of leucocytes, lymphocytes and neutrophiles compared with the non-fatigued, thus further indicating that an activation of the immune system plays a role in the biology of chronic fatigue in breast cancer survivors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Småstuen M, Aagnes B, Johannesen TB, Møller B, Bray F (2008) Long-Term Cancer Survival: Patterns and Trends in Norway 1965–2007 Cancer Registry of Norway: Oslo.
Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR . Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000; 18: 743–753.
Richardson A . Fatigue in cancer patients: a review of the literature. Eur J Cancer Care (Engl) 1995; 4: 20–32.
Servaes P, Verhagen S, Bleijenberg G . Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol 2002; 13: 589–598.
Andrykowski MA, Curran SL, Lightner R . Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med 1998; 21: 1–18.
Lindley C, Vasa S, Sawyer WT, Winer EP . Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 1998; 16: 1380–1387.
Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH . Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998; 16: 1689–1696.
Mast ME . Correlates of fatigue in survivors of breast cancer. Cancer Nurs 1998; 21: 136–142.
Bower JE, Ganz PA, Aziz N, Fahey JL . Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002; 64: 604–611.
Bower JE, Ganz PA, Aziz N, Fahey JL, Cole SW . T-cell homeostasis in breast cancer survivors with persistent fatigue. J Natl Cancer Inst 2003; 95: 1165–1168.
Bower JE, Ganz PA, Aziz N . Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med 2005; 67: 277–280.
Bower JE, Ganz PA, Dickerson SS, Petersen L, Aziz N, Fahey JL . Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005; 30: 92–100.
Bower JE . Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun 2007; 21: 863–871.
Bower JE, Ganz PA, Aziz N, Olmstead R, Irwin MR, Cole SW . Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids. Brain Behav Immun 2007; 21: 251–258.
Collado-Hidalgo A, Bower JE, Ganz PA, Cole SW, Irwin MR . Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 2006; 12: 2759–2766.
Alexander S, Minton O, Andrews P, Stone P . A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer 2009; 45: 384–392, e-pub 2008 Oct 30.
Zhan F, Hardin J, Kordsmeier B, Bummk K, Zhenq M, Tian E et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 2002; 99: 1745–1757.
Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S et al. The molecular classification of multiple myeloma. Blood 2006; 108: 2020–2028.
Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002; 8: 68–74.
Lu X, Nechushtan H, Ding F, Rosado MF, Singal R, Alizadeh AA et al. Distinct IL-4-induced gene expression, proliferation, and intracellular signaling in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas. Blood 2005; 105: 2924–2932.
Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 2003; 100: 1896–1901.
Silva M, Grillot D, Benito A, Richard C, Nuñez G, Fernández-Luna JL et al. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 1996; 88: 1576–1582.
Carey GB, Semenova E, Qi X, Keegan AD . IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway. Cell Res 2007; 17: 942–955.
Bower JE, Ganz PA, Aziz N, Olmstead R, Irwin MR, Cole SW . Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids. Brain Behav Immun 2007; 21: 251–258.
Holzner B, Kemmler G, Greil R, Kopp M, Zeimet A, Raderer M et al. The impact of hemoglobin levels on fatigue and quality of life in cancer patients. Ann Oncol 2002; 13: 965–973.
Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S . Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 2003; 98: 1786–1801.
Reinertsen KV, Cvancarova M, Wist E, Bjøro T, Dahl AA, Danielsen T et al. Thyroid function in women after multimodal treatment for breast cancer stage II/III: Comparison with controls from a population sample. Int J Radiat Oncol Biol Phys 2009 (e-pub ahead of print).
Chalder T, Berelowitz G, Pawlikowska T, Walts L, Wessely S, Wright D et al. Development of a fatigue scale. J Psychosom Res 1993; 37: 147–153.
Zigmond AS, Snaith RP . The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–370.
Lin SM, Du P, Huber W, Kibbe WA . Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res 2008; 36: e11.
Mansmann U, Meister R . Testing differential gene expression in functional groups. Goeman's global test versus an ANCOVA approach. Methods Inf Med 2005; 44: 449–453.
Benjamini Y, Hochberg Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Series B 1995; 57: 289–300.
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BC, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545–15550.
Acknowledgements
This work was supported by grants from the South-Eastern Norway Regional Health Authority (SE-NRH) (Grant number 6051-10920-39119); H Landmark-Høyvik is a research fellow at SE-NRH, and The Norwegian Cancer Society's Pink Ribbon foundation (Grant number 6260-10920-33141). We thank Caroline Frøyland for her technical assistance.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website (http://www.nature.com/tpj)
Supplementary information
Rights and permissions
About this article
Cite this article
Landmark-Høyvik, H., Reinertsen, K., Loge, J. et al. Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics J 9, 333–340 (2009). https://doi.org/10.1038/tpj.2009.27
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/tpj.2009.27
Keywords
This article is cited by
-
Biological mechanisms of cancer-related fatigue in breast cancer survivors after treatment: a scoping review
Journal of Cancer Survivorship (2023)
-
Chemotherapy-induced fatigue is associated with changes in gene expression in the peripheral blood mononuclear cell fraction of patients with locoregional breast cancer
Supportive Care in Cancer (2019)
-
Genetic contributions to self-reported tiredness
Molecular Psychiatry (2018)
-
Differential expression of genes and differentially perturbed pathways associated with very high evening fatigue in oncology patients receiving chemotherapy
Supportive Care in Cancer (2018)
-
Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression
Clinical and Translational Medicine (2015)